Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo

International Journal of Oncology

Volumn 8, Issue 6, 1996, Pages 1095-1104

  Rybak, Susanna M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

anti tumor ribonuclease; antibody conjugates; multidrug resistance

Indexed keywords

ANTIBODY CONJUGATE; GLYCOPROTEIN P; MONOCLONAL ANTIBODY MRK 16; RANPIRNASE; RIBONUCLEASE; UNCLASSIFIED DRUG; VINCRISTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 0029890589     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Ardelt A, Mikulski SM and Shogen K: Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. J Biol Chem 256: 245-251, 1991.
2. Darzynkiewicz Z, Carter SP, Mikulski SM, Ardelt WJ and Shogen K: Cytostatic and cytotoxic effects of Pannon (P-30 protein) a novel anti-cancer agent. Cell Tissue Kinet 21: 169-182, 1988.